Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Moffitt Cancer Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Moffitt Cancer Center brings 78 presentations to ASH 2026 in New Orleans, and exhibits at Booth 3623. Its research spans CAR T-cell therapy and myeloma, along with myelodysplastic syndromes and leukemia. It covers topics such as AI analysis of blood smears for diagnosis and how CAR T-cell therapy is delivered in community oncology practice.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
NCI-designated comprehensive cancer center in Tampa, Florida, working on cancer prevention, treatment, research and training.
Booth
Exhibiting at Booth 3623
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Advancing Bispecific Pathways in ALL: How Clinical Experience and New Science are Informing Off-the-Shelf Innovation
Bispecific T-cell engagers in B-cell acute lymphoblastic leukemia, including gentler next-generation versions for patients unsuited to or relapsing after CAR-T.
Symposium hosted by PeerView Institute for Medical Education
Leukemias · New drugs
Symposium
Fri Dec 11
11:00am–2:00pm
CAR T-Cell Agent Integration in Lymphoma: A Masterclass for Real-World Implementation
CAR-T for relapsed B-cell lymphomas, from patient selection and referral to managing immune and nerve toxicities, survivorship, and off-the-shelf products.
Symposium hosted by Decera Clinical Education
Lymphoma · Cell & gene
Symposium
Fri Dec 11
11:00am–2:00pm
CML Treatment Continuum: Optimizing Therapy Selection, Molecular Monitoring, And Long-Term Quality of Life
First-line drug choice, resistance, long-term side effects, and treatment-free remission in chronic myeloid leukemia, plus pipeline agents.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going
Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
MDS in the Modern Era: Getting Ahead of the 8-Ball
Moving myelodysplastic syndrome care toward early disease-modifying drugs, with hypomethylating agents for higher-risk disease and wider transplant access.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
Myeloma Challenge! Test Your Knowledge of Updated Guidelines and Evidence-Based Practice
Guideline-based myeloma care from smoldering disease to late relapse, including three- or four-drug regimens, residual disease testing, and newer immunotherapies.
Symposium hosted by National Comprehensive Cancer Network and Decera Clinical Education
Myeloma
Symposium
Fri Dec 11
3:00pm–6:00pm
The Rising Tide of Bispecifics in NHL: Off-the-Shelf Opportunities From Later-Line to Frontline Care
Bispecific antibodies moving from late to early treatment of non-Hodgkin lymphoma, with outpatient step-up dosing and control of immune side effects.
Symposium hosted by PeerView Institute for Medical Education
Lymphoma · New drugs
Session
Sun Dec 13
7:00am–9:00am
Medical Educators' Symposium
Practical strategies for medical educators on time management, wellness, inclusive learning spaces, and teaching with AI, apps, and social media.
Patient care
Session
Sun Dec 13
4:30pm–5:45pm
Are We There Yet? Improving Outcomes in MDS
Assessing and treating myelodysplastic syndromes, marrow failure cancers of older adults that can turn into acute myeloid leukemia, using newer risk systems.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Moffitt Cancer Center

Tell us what you sell and we’ll find the people at Moffitt Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction